Titan Bio-Tech [TITANBIO] vs Dishman Carbogen [DCAL] Detailed Stock Comparison

Titan Bio-Tech

BSE
Loading...

Dishman Carbogen

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Titan Bio-Tech wins in 9 metrics, Dishman Carbogen wins in 10 metrics, with 0 ties. Dishman Carbogen appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTitan Bio-TechDishman CarbogenBetter
P/E Ratio (TTM)35.7941.63Titan Bio-Tech
Price-to-Book Ratio5.130.74Dishman Carbogen
Debt-to-Equity Ratio1.8240.97Titan Bio-Tech
PEG Ratio4.99-0.32Dishman Carbogen
EV/EBITDA30.0310.48Dishman Carbogen
Profit Margin (TTM)13.76%3.60%Titan Bio-Tech
Operating Margin (TTM)16.31%8.38%Titan Bio-Tech
EBITDA Margin (TTM)16.31%8.38%Titan Bio-Tech
Return on Equity14.04%0.06%Titan Bio-Tech
Return on Assets (TTM)12.32%0.03%Titan Bio-Tech
Free Cash Flow (TTM)$106.79M$1.58BDishman Carbogen
Dividend Yield0.42%N/AN/A
1-Year Return33.04%62.68%Dishman Carbogen
Price-to-Sales Ratio (TTM)4.931.52Dishman Carbogen
Enterprise Value$7.85B$61.99BDishman Carbogen
EV/Revenue Ratio4.912.14Dishman Carbogen
Gross Profit Margin (TTM)48.49%86.15%Dishman Carbogen
Revenue per Share (TTM)$193$188Titan Bio-Tech
Earnings per Share (Diluted)$26.62$6.64Titan Bio-Tech
Beta (Stock Volatility)0.230.19Dishman Carbogen
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Titan Bio-Tech vs Dishman Carbogen Stock Performance Analysis

Loading Price Chart...

Titan Bio-Tech
Dishman Carbogen
Titan Bio-Tech Stock Overview | Dishman Carbogen Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Titan Bio-Tech1.69%7.36%37.60%123.15%104.11%26.96%
Dishman Carbogen3.11%1.33%6.52%11.35%26.46%-0.11%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Titan Bio-Tech33.04%252.87%522.82%3,129.33%2,862.69%5,150.95%
Dishman Carbogen62.68%168.99%66.89%66.23%209.69%261.11%

News Based Sentiment: Titan Bio-Tech vs Dishman Carbogen

Titan Bio-Tech

News based Sentiment: MIXED

September presented a mixed bag for Titan Biotech. While the company showcased impressive revenue growth and financial stability, the insider selling by a promoter raises concerns about confidence in the short-term outlook. This combination of positive and negative signals makes it a significant month for investors to assess the company's trajectory.

View Titan Bio-Tech News Sentiment Analysis

Dishman Carbogen

News based Sentiment: POSITIVE

Dishman Carbogen Amcis is showing a clear positive trend with strong revenue growth, improved profitability, and proactive financial management. The increase in authorized share capital and the ambitious EBITDA margin target signal confidence in future growth, making this a significant month for the company's investment story.

View Dishman Carbogen News Sentiment Analysis

Performance & Financial Health Analysis: Titan Bio-Tech vs Dishman Carbogen

MetricTITANBIODCAL
Market Information
Market Cap i₹8.10B₹45.33B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i31,282778,693
90 Day Avg. Volume i32,475385,564
Last Close₹968.80₹285.00
52 Week Range₹373.65 - ₹1,017.00₹161.21 - ₹321.95
% from 52W High-4.74%-11.48%
All-Time High₹1,017.85 (Oct 21, 2024)₹396.40 (Jan 22, 2018)
% from All-Time High-4.82%-28.10%
Growth Metrics
Quarterly Revenue Growth0.08%0.35%
Quarterly Earnings Growth0.07%0.35%
Financial Health
Profit Margin (TTM) i0.14%0.04%
Operating Margin (TTM) i0.16%0.08%
Return on Equity (TTM) i0.14%0.00%
Debt to Equity (MRQ) i1.8240.97
Cash & Liquidity
Book Value per Share (MRQ)₹185.75₹372.17
Cash per Share (MRQ)₹6.72₹33.89
Operating Cash Flow (TTM) i₹197.75M₹-199,700,000
Levered Free Cash Flow (TTM) i₹215.32M₹32.40M
Dividends
Last 12-Month Dividend Yield i0.42%N/A
Last 12-Month Dividend i₹4.00₹0.00

Valuation & Enterprise Metrics Analysis: Titan Bio-Tech vs Dishman Carbogen

MetricTITANBIODCAL
Price Ratios
P/E Ratio (TTM) i35.7941.63
Forward P/E iN/A22.11
PEG Ratio i4.99-0.32
Price to Sales (TTM) i4.931.52
Price to Book (MRQ) i5.130.74
Market Capitalization
Market Capitalization i₹8.10B₹45.33B
Enterprise Value i₹7.85B₹61.99B
Enterprise Value Metrics
Enterprise to Revenue i4.912.14
Enterprise to EBITDA i30.0310.48
Risk & Other Metrics
Beta i0.230.19
Book Value per Share (MRQ) i₹185.75₹372.17

Financial Statements Comparison: Titan Bio-Tech vs Dishman Carbogen

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TITANBIODCAL
Revenue/Sales i₹464.96M₹7.08B
Cost of Goods Sold i₹239.50M₹980.90M
Gross Profit i₹225.47M₹6.10B
Research & Development iN/AN/A
Operating Income (EBIT) i₹75.85M₹593.30M
EBITDA i₹94.59M₹1.65B
Pre-Tax Income i₹81.12M₹386.70M
Income Tax i₹19.51M₹152.60M
Net Income (Profit) i₹68.63M₹234.10M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TITANBIODCAL
Cash & Equivalents i₹51.28M₹2.86B
Total Current Assets i₹790.38M₹22.00B
Total Current Liabilities i₹177.36M₹19.25B
Long-Term Debt i₹4.19M₹13.90B
Total Shareholders Equity i₹1.53B₹58.32B
Retained Earnings i₹1.36B₹2.13B
Property, Plant & Equipment i₹571.62M₹10.27B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TITANBIODCAL
Operating Cash Flow i₹45.62MN/A
Capital Expenditures i₹-33.58MN/A
Free Cash Flow i₹12.24MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTITANBIODCAL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i31,282778,693
Average Daily Volume (90 Day) i32,475385,564
Shares Outstanding i8.26M156.78M
Float Shares i2.65M55.22M
% Held by Insiders i0.67%0.71%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Titan Bio-Tech vs Dishman Carbogen

MetricTITANBIODCAL
Last 12-Month Dividend i₹4.00₹0.00
Last 12-Month Dividend Yield i0.42%N/A
3-Year Avg Annual Dividend i₹1.93₹0.00
3-Year Avg Dividend Yield i0.34%N/A
3-Year Total Dividends i₹5.80₹0.00
Ex-Dividend DateSep 19, 2025N/A